RCYC
MRK icon

Richard C. Young & Co’s Merck MRK Stock Holding History

Richard C. Young & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
1,732
+4
+0.2% +$468 0.02% 98
2026
Q1 		$208K Buy
+1,728
New +$199K 0.02% 92
2025
Q2 		– Sell
-194,039
Closed -$17.4M – 88
2025
Q1 		$17.4M Sell
194,039
-2,807
-1% -$262K 1.87% 17
2024
Q4 		$19.6M Buy
196,846
+13
+0% +$1.34K 2.13% 11
2024
Q3 		$22.4M Buy
196,833
+1,421
+0.7% +$169K 2.44% 6
2024
Q2 		$24.2M Buy
195,412
+1,662
+0.9% +$214K 2.94% 3
2024
Q1 		$25.6M Sell
193,750
-2,179
-1% -$269K 3.21% 3
2023
Q4 		$21.4M Buy
195,929
+1,859
+1% +$193K 2.86% 4
2023
Q3 		$20M Sell
194,070
-313
-0.2% -$33.7K 2.84% 5
2023
Q2 		$22.4M Buy
194,383
+936
+0.5% +$106K 3.08% 4
2023
Q1 		$20.6M Sell
193,447
-3,082
-2% -$333K 2.83% 4
2022
Q4 		$21.8M Sell
196,529
-1,655
-0.8% -$169K 2.9% 4
2022
Q3 		$17.1M Sell
198,184
-17
-0% -$1.52K 2.61% 7
2022
Q2 		$18.1M Buy
198,201
+2,764
+1% +$245K 2.34% 9
2022
Q1 		$16M Buy
195,437
+475
+0.2% +$37.5K 2.05% 15
2021
Q4 		$14.4M Buy
194,962
+3,722
+2% +$296K 1.82% 21
2021
Q3 		$14.4M Buy
191,240
+2,115
+1% +$161K 1.97% 18
2021
Q2 		$14.7M Sell
189,125
-4,379
-2% -$326K 1.87% 18
2021
Q1 		$14.2M Buy
193,504
+8,959
+5% +$661K 1.89% 17
2020
Q4 		$14.4M Buy
184,545
+6,337
+4% +$485K 2.19% 13
2020
Q3 		$14.1M Buy
178,208
+53,356
+43% +$4.18M 2.27% 12
2020
Q2 		$9.21M Sell
124,852
-1,654
-1% -$125K 1.53% 28
2020
Q1 		$9.29M Buy
126,506
+2,999
+2% +$236K 1.8% 23
2019
Q4 		$10.7M Buy
123,507
+3,923
+3% +$322K 1.79% 22
2019
Q3 		$9.61M Buy
119,584
+2,064
+2% +$165K 1.73% 21
2019
Q2 		$9.4M Buy
117,520
+2,802
+2% +$215K 1.78% 21
2019
Q1 		$9.1M Buy
+114,718
New +$8.58M 1.74% 20

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Richard C. Young & Co's MRK Position: Q2 2026 in Review

Richard C. Young & Co increased its Merck (MRK) stake by 0.23% in Q2 2026, buying an estimated $468 and bringing the position to 1,732 shares worth $223K. The position accounts for 0.02% of the portfolio, ranked #98.

Richard C. Young & Co first reported a position in MRK in Q1 2019 and has held it in 27 quarters since. The position peaked at $25.6M in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Richard C. Young & Co held 1,732 shares of Merck worth $223K as of Q2 2026.
  • Richard C. Young & Co bought 4 Merck shares in Q2 2026, an estimated $468.
  • Merck made up 0.02% of Richard C. Young & Co's portfolio in Q2 2026, its #98 holding.
  • Richard C. Young & Co first reported a position in Merck in Q1 2019 and has held it in 27 quarters since.
  • Richard C. Young & Co's Merck position peaked at $25.6M in Q1 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Richard C. Young & Co's 13F filing for Q2 2026, filed 28 Jul 2026.